tauderma.com Report : Visit Site

Technical data of the tauderma.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host tauderma.com. Currently, hosted in Switzerland and its service provider is Infomaniak Network SA .

the related websites

cyclingnews.com thefa.com ncefl.org.uk enghteam.com ukandspain.com belbin.com bbc.co.uk mckinsey.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

-- -- -- -- -- en fr tauderma vision saxiline team partners contact en fr new assets for the cosmetics industry of tomorrow tauderma’s research teams, with their experience in the pharmaceutical industry and biotechnology, are advancing the development of assets for the cosmetics of tomorrow. rigorous scientific approach that substantiates the claim! we work on a targeted product profile (tpp) basis, a rational approach employed by a modern pharmaceutical and biotech industry. it means that on the basis of a relationship between the targeted cosmetic effect and current advances in biological science, we develop a coherent set of tests, from in vitro to in vivo, to identify extracts for a specific indication . this approach provides a clear and tangible focus and generates hard translational data to build on and to support the future claim for the finished cosmetic product. we are based in the swiss health valley , an international pole of excellence in bio-pharmaceutical and medical development. our expertise ranges from the development of highly selective molecular screening processes, advanced extraction technology to a rigorous pre-clinical and clinical development of our products. this process of developing new active principles is based not only on our internal skills (botany, biology, pharmacology, dermatology) and on our professional experience, but also on privileged relations with academic institutions and subcontractors specialized in toxicology, regulatory affairs and clinical development. this allows us to create new, innovative and patented extracts that provide differentiation in the cosmetics market. high-end swiss technology the technologies developed by tauderma have led to the development of exclusive extraction processes , specially designed to guarantee the purity and safety of our plant extracts and their active ingredients. in partnership with the most prestigious swiss academic institutions we have developed a solvent-free extraction process which guarantees the preservation of the active ingredients of an extract, thus making it the ideal component of a cosmetic line with high added value. all our extracts are tested according to the current legal and regulatory provisions and are subject to strict quality controls. advanced science the founders of tauderma are renowned doctors and scientists who have made their careers in the high-level healthcare industry. the expertise and methodologies employed within tauderma are directly derived from this experience. the rigorous scientific methods deployed throughout the development processes and during the production of its assets place tauderma in a unique position in the field of cosmetic extracts. a constant research effort carried out within tauderma since 2014 has allowed us to study 120 alpine plants and to already select several of them on the basis of a precisely defined tpp. also, this largely unexplored plant library offers an extraordinary potential for the discovery of new effective extracts. high-end swiss technology the technologies developed by tauderma have led to the development of exclusive extraction processes , specially designed to guarantee the purity and safety of our plant extracts and their active ingredients. in partnership with the most prestigious swiss academic institutions we have developed a solvent-free extraction process which guarantees the preservation of the active ingredients of an extract, thus making it the ideal component of a cosmetic line with high added value. all our extracts are tested according to the current legal and regulatory provisions and are subject to strict quality controls. advanced science the founders of tauderma are renowned doctors and scientists who have made their careers in the high-level healthcare industry. the expertise and methodologies employed within tauderma are directly derived from this experience. the rigorous scientific methods deployed throughout the development processes and during the production of its assets place tauderma in a unique position in the field of cosmetic extracts. a constant research effort carried out within tauderma since 2014 has allowed us to study 120 alpine plants and to already select several of them on the basis of a precisely defined tpp. also, this largely unexplored plant library offers an extraordinary potential for the discovery of new effective extracts. our vision active ingredients are often only a small percentage of the finished cosmetic product, however it is that percentage that makes the difference by delivering unique performance benefits. we believe that only innovative active ingredients with a proven efficacy/safety profile can bring added value to the future cosmetic products. values and ethics we only work with plants certified by bio swiss www.biosuisse.ch and provide preservative-free extracts , thanks to the use of cryogenic techniques. the production of our extracts is carried out under strict scientific control at all stages, according to internal procedures modeled on those very demanding ones of the healthcare industry. this approach meets the increasing demands of both regulatory agencies and consumers in terms of safety, efficacy, technology and respect for the environment. all our products meet the european legal standards for cosmetic use. the demonstrated effects of tauderma extracts skin spots tpp: decrease the overproduction of uv-induced melanin to slow the appearance of new spots and reduce the color of existing spots more1 a remarkable effect on pigmented spots was demonstrated in a double-blind, placebo-controlled clinical trial. the benefit compared to the placebo cream was already observed on the colorimetry tests on day 28 and the superiority was statistically significant at day 56. no adverse effects were reported (see chart below). saxi line reduces the brown color of skin dark spots without affecting the color of the skin around. to our knowledge there is no ingredient which has this specific effect as all the others whiten both the spot and the spotless area leading to an increase of the visibility of the spots. this effect, visible already after 1 month, has been measured using specific instruments (colorimetry) in a placebo control clinical study. measurement of dark spot lighting with the cream containing saxi line or the placebo measurement of spotless area lighting with the cream containing saxi line or the placebo skin firmness tpp: decrease the production of elastase and collagenase induced by uv radiation to preserve the elasticity of the skin more2 in vitro, saxi line showed a statistically significant inhibitory effect on the production of elastase and collagenase induced by uv exposure of human skin explants. in a clinical trial, saxi line demonstrated a statistically significant effect on the parameters of skin deformation induced by an air jet (surface, depth and volume) after one month of application of our cream compared to the parameters measured before application. in addition, saxi line showed a statistically significant superiority compared to the placebo for the two depth and volume parameters related to skin firmness (see chart below). effect of saxi line or placebo on skin deformation parameters after 28 days solar erythema tpp: alleviate the severity of solar erythema (soothing effect) more3 in another placebo-controlled clinical trial, saxi line showed a statistically significant superiority over placebo by markedly reducing uv-induced erythema. the soothing effect on irritated and reddened skin was observed after 6 hours and maintained a statistically significant superiority over the placebo at 24 hours and 48 hours after initiation of treatment. no adverse reactions have been reported (see chart below). effect of saxi line or placebo on skin color measured by chromametry following uv exposure acne this project is currently under development our teams remain at your disposal for any information on the integration of t

URL analysis for tauderma.com

http://www.tauderma.com//#tauderma
http://www.tauderma.com//mailto:[email protected]
http://www.tauderma.com//#more3-105989
http://www.tauderma.com/
http://www.tauderma.com//#tab-1464687519-1-18
http://www.tauderma.com
http://www.tauderma.com//mailto:[email protected]
http://www.tauderma.com//#team
http://www.tauderma.com//#tab-1464687519-2-97
http://www.tauderma.com///imprint
http://www.tauderma.com//#contact
http://www.tauderma.com//#more2-245030
http://www.tauderma.com//#partenaires
http://www.tauderma.com//#actifs
http://www.tauderma.com//tel:0041799448355

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: TAUDERMA.COM
Registry Domain ID: 1842911088_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.infomaniak.com
Registrar URL: http://www.infomaniak.com
Updated Date: 2017-10-26T17:20:19Z
Creation Date: 2014-01-15T07:06:01Z
Registry Expiry Date: 2018-01-15T07:06:01Z
Registrar: Infomaniak Network SA
Registrar IANA ID: 3240
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +41228203544
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS5.INFOMANIAK.CH
Name Server: NS6.INFOMANIAK.CH
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-11-17T05:09:44Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Infomaniak Network SA

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =tauderma.com

  PORT 43

  TYPE domain

DOMAIN

  NAME tauderma.com

  CHANGED 2017-10-26

  CREATED 2014-01-15

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS5.INFOMANIAK.CH 84.16.66.68

  NS6.INFOMANIAK.CH 84.16.67.68

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .